19Jul 2024
Type III Collagen Turnover and Canagliflozin Impact in CANVAS

Type III Collagen Turnover and Canagliflozin Impact in CANVAS

The study of the CANVAS Program examined type III collagen (COL III) turnover in participants with type 2 diabetes. Higher baseline levels of PRO-C3 and C3M were linked to increased cardiovascular risks. Canagliflozin treatment decreased PRO-C3 levels and increased CTX-III levels, indicating shifts in COL III turnover dynamics. These biomarkers are potential tools for monitoring the tissue remodeling effects of canagliflozin and similar treatments.

  • #endo-diabetology

Like

Save

Share